Author name: comtex

(NASDAQ:REPL), NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the “Class Period”). A class […]

ROSEN, LEADING INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPL GlobeNewswire July 25, 2025 NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action

NEW YORK, NY / ACCESS Newswire / July 24, 2025 / If you suffered a loss on your RxSight, Inc. (NASDAQ:RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=158068&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / July 24, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=158067&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

The Ademi Firm is investigating Synovus (NYSE: SNV) for possible breaches of fiduciary duty and other violations of law in its transaction with Pinnacle Financial Partners. https://mma.prnewswire.com/media/2672539/Ademi_Fruchter__Logo.jpg Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to

(NYSE:XIFR),(NYSE:CNC),(NYSE:BHVN),(NASDAQ:CAPR), If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648 NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally

Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits GlobeNewswire July 25, 2025 If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel &

The critically acclaimed, award-winning Hollywood actor and producer joins the luxury beauty brand, embodying its philosophy of Radiance. Introducing Nicole Kidman, Clé de Peau Beauté's new Global Brand Ambassador Clé de Peau Beauté, a global luxury skincare and makeup brand, is proud to announce Nicole Kidman as its new Global Brand Ambassador. Renowned for her

NEW YORK, NY / ACCESS Newswire / July 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Replimune Group, Inc. ("Replimune Group, Inc.") (NASDAQ:REPL) concerning possible violations of federal securities laws. On July 22, 2025, Replimune announced that it received a Complete Response Letter from the FDA rejecting its

NEW YORK CITY, NY / ACCESS Newswire / July 24, 2025 / WHY: New York, N.Y., July 24, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the "Class Period"), of the important August